Preparing for a Drug Launch: How Vanscoy Rare Pharmacy Sets the Stage for Success

February 17, 2026

Vanscoy Rare Pharmacy Selected as Exclusive Distribution Pharmacy for Redemplo® (plozasiran) for adults with Familial Chylomicronemia Syndrome (FCS)

February 10, 2026

The vIMPACT System: Revolutionizing Rare Therapy Commercialization

December 10, 2025

Supporting Patients with Rare Diseases: A Commitment to Care and Compassion

October 22, 2025

Celebrating National Pharmacist Month with Vanscoy Rare Pharmacy

October 2, 2025

Maximize the Benefits of Exclusive Distribution with Vanscoy Rare Pharmacy

September 23, 2025

Vanscoy Rare Pharmacy Achieves 50 State Licensure 

December 4, 2024

Vanscoy Rare Pharmacy Achieves Accreditation with URAC

October 9, 2024

Vanscoy Rare Pharmacy Achieves Accreditation with ACHC for Specialty Pharmacy and a Rare Diseases and Orphan Drugs Distinction

September 16, 2024

A Letter from Our CEO

July 1, 2024

Bet on the Jockey, Not the Horse

May 3, 2024

Introducing Vanscoy Rare Pharmacy: Founders of Rare Pharmacy Doing it Again, but Better

February 21, 2024